Cyclomics

Utrecht, The Netherlands

Cyclomics is a Dutch startup with ambition is to transform cancer care by enabling faster and more reliable diagnoses.

$3.0M raised

Jan 2026

Venture - Series Unknown

Top Investors

EISMEAOncode Oncology Bridge FundMyosotis Investments

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Cyclomics raised?

Cyclomics has raised $3.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2026.

Who are Cyclomics's investors?

Cyclomics's investors include EISMEA, Oncode Oncology Bridge Fund, Myosotis Investments.

Where is Cyclomics headquartered?

Cyclomics is headquartered in Utrecht, The Netherlands.

What does Cyclomics do?

Cyclomics is a Dutch startup with ambition is to transform cancer care by enabling faster and more reliable diagnoses.

What stage is Cyclomics at?

Cyclomics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 7, 2026.

MLA

"Cyclomics — Funding & Investors." VCBacked, January 7, 2026, https://www.vcbacked.co/company/cyclomics. Accessed June 3, 2026.

APA

VCBacked. (2026). Cyclomics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/cyclomics

Wikipedia (cite web)

{{cite web |title=Cyclomics — Funding & Investors |url=https://www.vcbacked.co/company/cyclomics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 7, 2026.